SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wang MH,Wang D,Chen YQ. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Carcinogenesis. 2003; 24: 12911300.
  • 2
    Leonard EJ,Danilkovitch A. Macrophage stimulating protein. Adv Cancer Res. 2000; 77: 139167.
  • 3
    Danilkovitch-Miagkova A. Oncogenic signaling pathways activated by RON receptor tyrosine kinase. Curr Cancer Drug Targets. 2003; 3: 3140.
  • 4
    Summy JM,Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003; 22: 337358.
  • 5
    Danilkovitch A,Donley S,Skeel A,Leonard EJ. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol. 2000; 20: 22182227.
  • 6
    Thiery JP,Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 1999; 18: 3142.
  • 7
    Hsu MY,Wheelock MJ,Johnson KR,Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc. 1996; 1: 188194.
  • 8
    Birchmeier W,Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994; 1198: 1126.
  • 9
    Scheumman GF,Hoang-Vu C,Cetin Y, et al. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab. 1995; 80: 21682172.
  • 10
    Chen YQ,Zhou YQ,Angeloni D, et al. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines. Exp Cell Res. 2000; 261: 229238.
  • 11
    Maggiora P,Marchio S,Stella MC, et al. Overexpression of the RON gene in human breast carcinoma. Oncogene. 1998; 16: 29272933.
  • 12
    Maggiora P,Lorenzato A,Fracchioli S, et al. The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. Exp Cell Res. 2003; 288: 382389.
  • 13
    Hruban RH,Adsay NV,Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001; 25: 579586.
  • 14
    O'Toole JM,Rabenau KE,Burns K, et al. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Res. 2006; 66: 91629170.
  • 15
    Yang J,Mani SA,Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117: 927939.
  • 16
    Kang Y,Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004; 118: 277279.
  • 17
    Batlle E,Sancho E,Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2: 8489.
  • 18
    Cano A,Perez-Moreno MA,Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2: 7683.
  • 19
    Vandesompele J,De Preter K,Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: RESEARCH0034.
  • 20
    Jung YD,Liu W,Reinmuth N, et al. Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis. 2001; 4: 155162.
  • 21
    Bruns CJ,Harbison MT,Kuniyasu H,Eue I,Fidler IJ. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia. 1999; 1: 5062.
  • 22
    Elliott BE,Hung WL,Boag AH,Tuck AB. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can J Physiol Pharmacol. 2002; 80: 91102.
  • 23
    Lu Z,Ghosh S,Wang Z,Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell. 2003; 4: 499515.